{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:38:49Z","timestamp":1767843529927,"version":"3.49.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100031082","name":"Fabrikant Vilhelm Pedersen og Hustrus Legat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To describe antibiotic use in patients with inflammatory arthritis (IA) and in the background population (BP) within one year before and after IA diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using data from Danish nationwide registries, we identified all adults with a first-time diagnosis of RA, PsA, or AS\/spondyloarthritis (AS\/SpA) from 2010 through 2018. For each IA patient, we randomly sampled 10 persons from the BP, matched on sex and birthdate. We calculated the prevalence (n [%]) of any antibiotic dispensing and the total antibiotic dispensing in the year before and after diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 28\u2009504 new-onset IA patients (RA, n\u2009=\u200916\u2009130; PsA, n\u2009=\u20095988; AS\/SpA, n\u2009=\u20096386) and 285\u2009040 BP individuals. Within one year before diagnosis, the total amount of dispensed antibiotics was higher in both RA, PsA and As\/SpA compared with the BP (prevalence rate ratios [PRR], 1.48 [1.46; 1.51]; 1.67 [1.62; 1.72]; 1.52 [1.47; 1.56], respectively). The amount increased with 22% in IA patients three months before diagnosis compared with the preceding three-month period.\u00a0 Although the prevalence of any antibiotic dispensing in IA patients decreased in the year following the diagnosis (IA; 40.6%), the total one-year antibiotic dispensing remained constant in RA (PRR 0.99 [0.97; 1.01]), decreased in PsA (0.91 [0.87; 0.94]) and increased in AS\/SpA (1.08 [1.04; 1.12]) patients after diagnosis compared with before.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Antibiotics are more frequently dispensed to individuals developing IA compared with the BP. Antibiotic utilization patterns change after IA diagnosis with marked differences among IA subgroups.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae396","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T22:37:17Z","timestamp":1724711837000},"page":"1705-1714","source":"Crossref","is-referenced-by-count":2,"title":["Antibiotics in inflammatory arthritis and background population one year before and after diagnosis: a nationwide drug utilization study"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-9065","authenticated-orcid":false,"given":"Maja S","family":"Kragsnaes","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nickolaj","family":"Risbo","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Aarhus,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2531-9547","authenticated-orcid":false,"given":"Jens Kristian","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Obel","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet , Copenhagen,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Finckh","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine and Department of Medicine, Faculty of Medicine, Geneva University Hospitals , Geneva,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma B","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital , Aarhus,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aarhus University , Aarhus,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-4962","authenticated-orcid":false,"given":"Torkell","family":"Ellingsen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Odense University Hospital , Odense,","place":["Denmark"]},{"name":"Department of Clinical Research, University of Southern Denmark , Odense,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"2025040212123371800_keae396-B1","doi-asserted-by":"crossref","first-page":"j3248","DOI":"10.1136\/bmj.j3248","article-title":"Diagnosis and early management of inflammatory arthritis","volume":"358","author":"Ledingham","year":"2017","journal-title":"BMJ"},{"key":"2025040212123371800_keae396-B2","doi-asserted-by":"crossref","first-page":"e001163","DOI":"10.1136\/rmdopen-2019-001163","article-title":"Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis","volume":"6","author":"Beers-Tas","year":"2020","journal-title":"RMD Open"},{"key":"2025040212123371800_keae396-B3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/acr.20496","article-title":"Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2025040212123371800_keae396-B4","doi-asserted-by":"crossref","first-page":"491160","DOI":"10.3389\/fcimb.2020.491160","article-title":"Mini-review: human microbiome and rheumatic diseases","volume":"10","author":"Vural","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2025040212123371800_keae396-B5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3899\/jrheum.210006","article-title":"Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: a set of parallel case-control studies","volume":"49","author":"Meer","year":"2022","journal-title":"J Rheumatol"},{"key":"2025040212123371800_keae396-B6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm.3914","article-title":"The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"2025040212123371800_keae396-B7","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/ard-2022-222871","article-title":"Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis","volume":"81","author":"Cheng","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025040212123371800_keae396-B8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025040212123371800_keae396-B9","doi-asserted-by":"crossref","first-page":"921675","DOI":"10.3389\/fmed.2022.921675","article-title":"Gut microbiota structure and metabolites, before and after treatment in early rheumatoid arthritis patients: a pilot study","volume":"9","author":"Marazzato","year":"2022","journal-title":"Front Med"},{"key":"2025040212123371800_keae396-B10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.42616","article-title":"Alteration of gut microbiota in individuals at high-risk for rheumatoid arthritis associated with disturbed metabolome and the initiation of arthritis through the triggering of mucosal immunity imbalance","volume":"75","author":"Luo","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025040212123371800_keae396-B11","doi-asserted-by":"crossref","first-page":"pbad023","DOI":"10.1093\/pcmedi\/pbad023","article-title":"Investigating the gut microbiota's influence on psoriasis and psoriatic arthritis risk: a Mendelian randomization analysis","volume":"6","author":"Yu","year":"2023","journal-title":"Precis Clin Med"},{"key":"2025040212123371800_keae396-B12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/acr2.11604","article-title":"Small intestinal permeability and metabolomic profiles in feces and plasma associate with clinical response in patients with active psoriatic arthritis participating in a fecal microbiota transplantation trial: exploratory findings from the FLORA trial","volume":"5","author":"Kragsnaes","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2025040212123371800_keae396-B13","first-page":"keac454","article-title":"Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation which are reversed by inflammation control","volume":"10","author":"Audo","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212123371800_keae396-B14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/art.42370","article-title":"Association of antibodies to Prevotella copri in anti-cyclic citrullinated peptide-positive individuals at risk of developing rheumatoid arthritis and in patients with early or established rheumatoid arthritis","volume":"75","author":"Seifert","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025040212123371800_keae396-B15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/annrheumdis-2019-216631","article-title":"The microbiome in rheumatology: where are we and where should we go?","volume":"79","author":"Manasson","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025040212123371800_keae396-B16","doi-asserted-by":"crossref","first-page":"110649","DOI":"10.1016\/j.celrep.2022.110649","article-title":"Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults","volume":"39","author":"Anthony","year":"2022","journal-title":"Cell rep"},{"key":"2025040212123371800_keae396-B17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-021-03986-2","article-title":"Unravelling the collateral damage of antibiotics on gut bacteria","volume":"599","author":"Maier","year":"2021","journal-title":"Nature"},{"key":"2025040212123371800_keae396-B18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/rheumatology\/kez452","article-title":"Influence of prior antibiotic use on risk of rheumatoid arthritis: case control study in general practice","volume":"59","author":"Armstrong","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212123371800_keae396-B19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-019-1394-6","article-title":"Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control study","volume":"17","author":"Sultan","year":"2019","journal-title":"BMC Med"},{"key":"2025040212123371800_keae396-B20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3899\/jrheum.140348","article-title":"Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group's greater susceptibility to infections?","volume":"42","author":"Arvonen","year":"2015","journal-title":"J Rheumatol"},{"key":"2025040212123371800_keae396-B21","doi-asserted-by":"crossref","first-page":"e003333","DOI":"10.1136\/rmdopen-2023-003333","article-title":"Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study","volume":"9","author":"Hestetun","year":"2023","journal-title":"RMD Open"},{"key":"2025040212123371800_keae396-B22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025040212123371800_keae396-B23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025040212123371800_keae396-B24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/acr.23426","article-title":"Impact of sustained remission on the risk of serious infection in patients with rheumatoid arthritis","volume":"70","author":"Accortt","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2025040212123371800_keae396-B25","first-page":"261","article-title":"Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era","volume":"34","author":"Galicia-Hern\u00e1ndez","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"2025040212123371800_keae396-B26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2025040212123371800_keae396-B27","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2025040212123371800_keae396-B28","first-page":"717","article-title":"The Danish unique personal identifier and the Danish Civil Registration System as a tool for research and quality improvement","volume":"31","author":"Mainz","year":"2019","journal-title":"Int J Qual Health Care"},{"key":"2025040212123371800_keae396-B29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/CLEP.S141438","article-title":"Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry","volume":"9","author":"Ibfelt","year":"2017","journal-title":"Clin Epidemiol"},{"key":"2025040212123371800_keae396-B30","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2147\/CLEP.S175406","article-title":"Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry","volume":"10","author":"Linauskas","year":"2018","journal-title":"Clin Epidemiol"},{"key":"2025040212123371800_keae396-B31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10654-004-1025-0","article-title":"Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry","volume":"19","author":"Pedersen","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"2025040212123371800_keae396-B32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/03009742.2022.2066807","article-title":"Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register","volume":"52","author":"Wallman","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"2025040212123371800_keae396-B33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/03009742.2015.1010572","article-title":"Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register","volume":"44","author":"Lindstr\u00f6m","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"2025040212123371800_keae396-B34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/03009742.2022.2064183","article-title":"How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort","volume":"52","author":"Lindqvist","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"2025040212123371800_keae396-B35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/acr.24111","article-title":"Spondyloarthritis and outcomes in pregnancy and labor: a Nationwide Register-based cohort study","volume":"73","author":"M\u00f8rk","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025040212123371800_keae396-B36","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.2015-2696","article-title":"Use of antibiotics and risk of type 2 diabetes: a population-based case-control study","volume":"100","author":"Mikkelsen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040212123371800_keae396-B37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2017.06.001","article-title":"Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity","volume":"82","author":"Watad","year":"2017","journal-title":"J Autoimmun"},{"key":"2025040212123371800_keae396-B38","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1016\/S2665-9913(20)30064-3","article-title":"Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional study","volume":"2","author":"Wells","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2025040212123371800_keae396-B39","doi-asserted-by":"crossref","first-page":"e01202","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"eLife"},{"key":"2025040212123371800_keae396-B40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41584-021-00585-3","article-title":"The gut\u2013joint axis in rheumatoid arthritis","volume":"17","author":"Zaiss","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025040212123371800_keae396-B41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025040212123371800_keae396-B42","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s10067-020-05065-9","article-title":"Elevated CRP even at the first visit to a rheumatologist is associated with long-term poor outcomes in patients with psoriatic arthritis","volume":"39","author":"Haroon","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2025040212123371800_keae396-B43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/rheumatology\/keab565","article-title":"Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort","volume":"61","author":"Pina Vegas","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212123371800_keae396-B44","doi-asserted-by":"crossref","first-page":"115033","DOI":"10.1016\/j.socscimed.2022.115033","article-title":"Prescribing antibiotics: factors driving decision-making in general practice. A discrete choice experiment","volume":"305","author":"Sydenham","year":"2022","journal-title":"Soc Sci Med"},{"key":"2025040212123371800_keae396-B45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3899\/jrheum.121192","article-title":"Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis","volume":"40","author":"Barber","year":"2013","journal-title":"J Rheumatol"},{"key":"2025040212123371800_keae396-B46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/02813432.2017.1333321","article-title":"Clinical indications for antibiotic use in Danish general practice: results from a nationwide electronic prescription database","volume":"35","author":"Aabenhus","year":"2017","journal-title":"Scand J Prim Health Care"},{"key":"2025040212123371800_keae396-B47","doi-asserted-by":"crossref","first-page":"e2315872","DOI":"10.1001\/jamanetworkopen.2023.15872","article-title":"Therapeutic equivalence of biosimilar and reference biologic drugs in rheumatoid arthritis: a systematic review and meta-analysis","volume":"6","author":"Ascef","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025040212123371800_keae396-B48","doi-asserted-by":"crossref","first-page":"105673","DOI":"10.1016\/j.jbspin.2023.105673","article-title":"Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: a meta-analysis of randomized controlled trials","volume":"91","author":"S\u00e9auve","year":"2024","journal-title":"Joint Bone Spine"},{"key":"2025040212123371800_keae396-B49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12879-019-3964-9","article-title":"Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark","volume":"19","author":"Kristensen","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2025040212123371800_keae396-B50","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/antibiotics11111615","article-title":"Changes in antibiotic prescribing patterns in Danish general practice during the COVID-19 pandemic: a register-based study","volume":"11","author":"Nymand","year":"2022","journal-title":"Antibiotics (Basel)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae396\/58967101\/keae396.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1705\/58967101\/keae396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1705\/58967101\/keae396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T18:14:33Z","timestamp":1743617673000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1705\/7742484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,27]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae396","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,8,27]]}}}